Overprescribing of proton pump inhibitors draining NHS funds

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.544, 2008-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypomagnesemia and proton-pump inhibitors

By Famularo Giuseppe Gasbarrone Laura Minisola Giovanni

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 709-716

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of proton pump inhibitors

By Furuta Takahisa Shirai Naohito Sugimoto Mitsushige Ohashi Kyoichi Ishizaki Takashi

Pharmacogenomics, Vol. 5, Iss. 2, 2004-03 ,pp. : 181-202

Future Medicine

Access to resources Recommend Favorite

Formulary Management of Proton Pump Inhibitors

By Byrne M.F. Murray F.E.

PharmacoEconomics, Vol. 16, Iss. 3, 1999-09 ,pp. : 225-246

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Proton Pump Inhibitors in Children

By Litalien Catherine Théorêt Yves Faure Christophe

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 441-466

Adis International

Access to resources Recommend Favorite

Update on the pharmacogenomics of proton pump inhibitors

By Hagymáási Krisztina Müüllner Katalin Herszéényi Láászlóó Tulassay Zsolt

Pharmacogenomics, Vol. 12, Iss. 6, 2011-06 ,pp. : 873-888

Future Medicine

Access to resources Recommend Favorite